Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. - Wikidata - awgldk - TriplyDB

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

http://www.wikidata.org/entity/Q41644055

about

CCAAT-enhancer-binding protein-beta expression in vivo is associated with muscle strength PPARs and the cardiovascular system Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders Sirtuins Link Inflammation and Metabolism PPARγ and the Innate Immune System Mediate the Resolution of Inflammation Macrophages in vascular inflammation--From atherosclerosis to vasculitis Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis The atypical PKCs in inflammation: NF-κB and beyond Tissue-resident macrophages Mitochondria in the regulation of innate and adaptive immunity The immune system's involvement in obesity-driven type 2 diabetes The immune system as a sensor of the metabolic state Myeloid heme oxygenase-1 haploinsufficiency reduces high fat diet-induced insulin resistance by affecting adipose macrophage infiltration in mice Deletion of macrophage Vitamin D receptor promotes insulin resistance and monocyte cholesterol transport to accelerate atherosclerosis in mice.The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity Distinct Hepatic Macrophage Populations in Lean and Obese Mice Astaxanthin as a Potential Protector of Liver Function: A Review Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis Macrophage plasticity and polarization: in vivo veritas Macrophage biology in development, homeostasis and disease Adipokines in inflammation and metabolic disease Adipose tissue macrophage in immune regulation of metabolism.PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Phenotypic polarization of macrophages in atherosclerosis Nuclear receptors as drug targets for metabolic disease.Regulation of learning and memory by meningeal immunity: a key role for IL-4 Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders Commensal bacteria at the interface of host metabolism and the immune system.Physical exercise reduces the expression of RANTES and its CCR5 receptor in the adipose tissue of obese humans Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance.Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments C/EBPα regulates macrophage activation and systemic metabolism.Inflammation, microglia, and Alzheimer's disease.Macrophage CGI-58 deficiency activates ROS-inflammasome pathway to promote insulin resistance in mice

P2860

Q24620519-EBE23CAD-0223-40C4-8ECD-1EDD6EEE45E5 Q24642728-662B916D-8088-4512-8CFD-67A66BAF5F53 Q24645182-BA8EAB14-1F22-4B0F-BD54-2445D0B3561E Q24650398-A771B475-B3A8-4EF6-88B0-DAC021C86CE4 Q26746997-0F730EA3-6474-42B8-BBDE-9D250865E223 Q26751258-3A339AAE-8321-4739-8161-3814A0D16703 Q26752618-8264B377-8BDB-48E1-A12D-727387C446EC Q26767141-549A8C22-8439-45FF-B151-CD2D824BC9FB Q26771755-9CBADD92-249B-4672-A270-06494BD27596 Q26825052-B7FB1964-CE6E-4561-80AC-C0F564D43351 Q26825467-FA0DA3D6-D7A8-428E-9B18-0C993B2B4584 Q26827479-60197FB1-B6C8-461D-B958-ED7239BBEE9A Q26829823-F37E8CE7-C4AA-488C-8572-93423E2C878E Q26991488-A378AA91-D3C4-4885-B769-9CDD68372506 Q26992186-E7E822F9-9198-4FA9-8455-BE9C1D8C2D0B Q27001164-FD646B86-4CF7-4FDA-B0E1-99FD6C7701C8 Q27026072-C7611AF1-DE85-4B57-81D9-EA161975B664 Q27301363-59BD61B4-19B4-4EE1-B2C9-18F50D1B2FD8 Q27321022-57EDBCDE-4E30-4E47-A214-E91D48F20773 Q27322096-3881A79B-2823-45C3-BD18-33E8DF0FA22F Q28069725-D5F8FABA-98CD-4A20-BA79-EAD4467CE3C3 Q28070358-99317069-DEC4-4FC0-8218-EC44780BAF69 Q28513911-1D8266C7-DC96-437F-A3CF-E2B8114BC4CE Q28591246-9CB4B0EA-A51C-46FB-8775-BBE6F41D1CB8 Q29547620-75251F7B-ED10-4FF8-AA8F-365965A6FA63 Q29620350-0F41E711-BAF5-4F58-8C44-CE015D112048 Q29620456-5468AD39-30D1-4F8E-8202-F40E80F9D681 Q30241406-1B81D0E6-8E6B-41E3-A97E-C199C68F54E6 Q30241952-D8583EBC-B6B7-46B1-B87D-27B7F17C19B2 Q30412717-1D0C4837-A46A-4300-8BDC-2D61988AC666 Q30430126-0877D52D-B6E6-4AD8-A687-DBE4694369F3 Q30434189-4E981090-807C-4C5B-9CF1-5E828E9FB5FC Q33166521-D542A564-82C4-4964-86B1-2DA582A1198C Q33578547-7EC382CF-DBD0-4AD6-B969-866373E9567C Q33594449-4BF927F2-9607-42D6-AF7E-4651A75466B0 Q33604466-330C062F-5C32-4867-B289-465BA62F1FF0 Q33616887-58066BC3-2B35-461E-8050-0579F5C1319B Q33628082-B271D5F3-FD03-468A-A5FB-D6B0E0B9FCC5 Q33664099-13BFC83C-504A-4E7D-B54C-63F56DAAC0A2 Q33693237-BB617BCE-3688-44B5-A067-F0790F7830C3

P2860

Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance.

http://www.wikidata.org/entity/Q41644055

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Alternative M2 activation of K ...... ty-induced insulin resistance.

@en

type

label

Alternative M2 activation of K ...... ty-induced insulin resistance.

@en

prefLabel

Alternative M2 activation of K ...... ty-induced insulin resistance.

@en

P1433

Q41644055-DAE31DFE-7017-4AD4-8BE5-1CE5F575048A

P1476

Q41644055-A0721ACB-946A-4083-AE4E-8CF6BE80B65B

P2093

Q41644055-44FFF9DF-0331-4ACD-B022-9EF8DE1E82FD

Q41644055-8015BC2B-EF41-410E-A85E-51A7D99FCB7D

Q41644055-86E68422-DD7A-4828-9E2C-1B807FDFB89F

Q41644055-8D9CBC2B-734D-48DF-8B38-054568F06BE6

Q41644055-C7A7BAC8-67C0-4CE8-80F4-E44D1E3F839C

Q41644055-EAA49D86-E5F3-4BE9-8E73-17D0BBF91A1C

Q41644055-F1B3FB8A-03E2-4423-B74B-A87296027B9D

Q41644055-FA94E92B-4B9F-4556-A0C6-EBF954F8BF84

Q41644055-FEAD49DE-29B9-4B39-8FC4-4EAC64284627

P2860

Q41644055-02859CBB-BDEA-47CC-AD40-F46918CA7ADB

Q41644055-06AD2231-CC82-4B22-972C-EB7355BA7FBD

Q41644055-165643F6-979D-4B22-9EE3-48467F64DD0F

Q41644055-16AC9150-B785-48E3-8CB7-CC1A8CBFECC1

Q41644055-1BB2FFF4-C27D-45C8-8AC1-02BC01F7DE83

Q41644055-220266A0-1696-4D04-AA7B-9FF08463662C

Q41644055-27DD37F0-77E4-4AEC-A9ED-EC9ED460F77A

Q41644055-29BB834A-21A2-4FF5-BB4D-EF34B8338102

Q41644055-2F98CCF2-D220-4F88-A784-291170DE8738

Q41644055-32770997-B796-40EB-851C-C330EA7967A4

P304

Q41644055-6C90E639-C78C-4CEC-9351-50D7E74C704E

P31

Q41644055-2B6A943B-6CBE-488E-8A51-78B6E238F652

P356

Q41644055-37BD8926-3843-4F4E-AF4D-B8056AEB376B

P433

Q41644055-6AFCF716-87BA-4466-B434-ACC9C2255554

P478

Q41644055-485B6F89-6D92-429A-84E7-0F2EF0990211

P50

Q41644055-C355A4DE-B7EB-423C-B4DC-672E30C8E15D

P577

Q41644055-1BAA1187-205A-4697-B604-F58F341BFFA7

P5875

Q41644055-DBA0DB59-3D65-44B3-966F-10A612C7F088

P698

Q41644055-3C826BD8-A482-46A3-97C7-DCA9B087553B

P921

Q41644055-31CF39AF-B5F1-47C2-8A70-EE8362509222

Q41644055-A72B638D-E991-4BB2-A896-C6B1590E95FE

P932

Q41644055-86F295E0-AC25-416D-9D0F-7466483E6D4B

P356

J.CMET.2008.04.003

P1433

Cell Metabolism

P1476

Alternative M2 activation of K ...... ity-induced insulin resistance

@en

P2093

Ajay Chawla

http://www.w3.org/2001/XMLSchema#string

Alex Red Eagle

http://www.w3.org/2001/XMLSchema#string

Anthony W Ferrante

http://www.w3.org/2001/XMLSchema#string

Christine R Morel

http://www.w3.org/2001/XMLSchema#string

Divya Vats

http://www.w3.org/2001/XMLSchema#string

Justin I Odegaard

http://www.w3.org/2001/XMLSchema#string

Lata Mukundan

http://www.w3.org/2001/XMLSchema#string

Matthew H Goforth

http://www.w3.org/2001/XMLSchema#string

Vidya Subramanian

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

Inflammation and insulin resistance

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation

Inflammation and metabolic disorders

Alternative activation of macrophages

Obesity is associated with macrophage accumulation in adipose tissue

P304

496-507

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CMET.2008.04.003

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Roberto R Ricardo-Gonzalez

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51399213

http://www.w3.org/2001/XMLSchema#string

P698

18522831

http://www.w3.org/2001/XMLSchema#string

P921

P932

2587370

http://www.w3.org/2001/XMLSchema#string